TY  - JOUR
AU  - Albain KS
AU  - Crowley JJ
AU  - LeBlanc M
AU  - Livingstone RB
TI  - Survival determinants in extensive-stage non-small cell lung cancer: the Southwest Oncology Group experience
JA  - J Clin Oncol
PY  - 1991///
VL  - 9
SP  - 1618
EP  - 1626
PB  - Cancer Research Campaign
ER  - 

TY  - JOUR
AU  - Ardizzoni A
AU  - Grossi F
AU  - Scolaro T
AU  - Giudici S
AU  - Foppiano F
AU  - Boni L
AU  - Tixi L
AU  - Cosso M
AU  - Mereu C
AU  - Battista Ratto G
AU  - Vitale V
AU  - Rosso R
TI  - Induction chemotherapy followed by concurrent standard radiotherapy and daily low-dose cisplatin in locally advanced non-small-cell lung cancer
JA  - Br J Cancer
PY  - 1999///
VL  - 81
SP  - 310
EP  - 315
PB  - Cancer Research Campaign
M3  - 10.1038/sj.bjc.6690693
N1  - 10.1038/sj.bjc.6690693
UR  - http://dx.doi.org/10.1038/sj.bjc.6690693
ER  - 

TY  - JOUR
AU  - Arriagada R
AU  - Kramar A
AU  - Le Chevalier T
AU  - De Cremoux H
TI  - Competing events determining relapse-free survival in limited small-cell lung carcinoma
JA  - J Clin Oncol
PY  - 1992///
VL  - 10
SP  - 447
EP  - 451
PB  - Cancer Research Campaign
ER  - 

TY  - JOUR
AU  - Ball D
AU  - Bishop J
AU  - Smith J
AU  - O/'Brien P
AU  - Davis S
AU  - Ryan G
AU  - Olver I
AU  - Toner G
AU  - Walker Q
AU  - Joseph D
TI  - A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial
JA  - Radiother Oncol
PY  - 1999///
VL  - 52
SP  - 129
EP  - 136
PB  - Cancer Research Campaign
M3  - 10.1016/S0167-8140(99)00093-6
N1  - 10.1016/S0167-8140(99)00093-6
UR  - http://dx.doi.org/10.1016/S0167-8140(99)00093-6
ER  - 

TY  - JOUR
AU  - Bentzen SM
AU  - Poulsen HS
AU  - Kaae S
AU  - Myhre Jensen O
AU  - Johansen H
AU  - Mouridsen HT
AU  - Daugaard S
AU  - Arnoldi C
TI  - Prognostic factors in osteosarcomas A regression analysis
JA  - Cancer
PY  - 1988///
VL  - 62
SP  - 194
EP  - 202
PB  - Cancer Research Campaign
ER  - 

TY  - JOUR
AU  - Bentzen SM
AU  - Thames HD
AU  - Travis EL
AU  - Kian Ang K
AU  - Van Der Scheren E
AU  - Dewit L
AU  - Dixon DO
TI  - Direct estimation of latent time for radiation injury in late responding normal tissues: gut, lung, and spinal cord
JA  - Int J Radiat Oncol Biol Phys
PY  - 1989///
VL  - 55
SP  - 27
EP  - 43
PB  - Cancer Research Campaign
ER  - 

TY  - GEN
TI  - 
JA  - 
PY  - 1992a///
VL  - 
SP  - 825
EP  - 864
PB  - Cancer Research Campaign
ER  - 

TY  - GEN
TI  - 
JA  - 
PY  - 1992b///
VL  - 
SP  - 825
EP  - 864
PB  - Cancer Research Campaign
ER  - 

TY  - JOUR
AU  - Chapman JW
AU  - Fish EB
AU  - Link MA
TI  - Competing risk analyses for recurrence from primary breast cancer
JA  - Br J Cancer
PY  - 1999///
VL  - 79
SP  - 1508
EP  - 1513
PB  - Cancer Research Campaign
M3  - 10.1038/sj.bjc.6690240
N1  - 10.1038/sj.bjc.6690240
UR  - http://dx.doi.org/10.1038/sj.bjc.6690240
ER  - 

TY  - JOUR
AU  - Ciampi A
AU  - Lawless JF
AU  - Mc Kinney SM
AU  - Singhal K
TI  - Regression and recursive partition strategies in the analysis of medical survival data
JA  - J Clin Epidemiol
PY  - 1988///
VL  - 41
SP  - 737
EP  - 748
PB  - Cancer Research Campaign
ER  - 

TY  - JOUR
AU  - Cox JD
AU  - Scott CB
AU  - Byhardt RW
AU  - Emami B
AU  - Russell AH
AU  - Fu KK
AU  - Parliament MB
AU  - Komaki R
AU  - Gaspar LEW
TI  - Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCLC): Analysis of Radiation Therapy Oncology Group (RTOG) trials
JA  - Int J Radiat Oncol Biol Phys
PY  - 1999///
VL  - 43
SP  - 505
EP  - 509
PB  - Cancer Research Campaign
ER  - 

TY  - GEN
AU  - Kalbfleisch JD
AU  - Prentice RL
TI  - 
JA  - The statistical Analysis of Failure Time Data
PY  - 1980///
VL  - 
SP  - 21
EP  - 38
PB  - Cancer Research Campaign
ER  - 

TY  - JOUR
AU  - Komaki R
AU  - Scott CB
AU  - Byhardt R
AU  - Emami B
AU  - Asbell SO
AU  - Russell AH
AU  - Roach M
AU  - Parliament MB
AU  - Gaspar LE
TI  - Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four radiation therapy oncology group (RTOG) studies in inoperable nonsmall-cell lung cancer (NSCLC)
JA  - Int. J. Radiat Oncol Biol. Phys
PY  - 1998///
VL  - 42
SP  - 263
EP  - 267
PB  - Cancer Research Campaign
ER  - 

TY  - JOUR
AU  - Kramar A
AU  - Pejovic MH
AU  - Chassagne D
TI  - A method of analysis taking into account competing events: Application to the study of digestive complications following irradiation for cervical cancer
JA  - Statist Med
PY  - 1987///
VL  - 6
SP  - 785
EP  - 794
PB  - Cancer Research Campaign
ER  - 

TY  - JOUR
AU  - Lagakos SW
TI  - A covariate model for partially censored data subject to competing causes of failure
JA  - Appl Statist
PY  - 1978///
VL  - 27
SP  - 235
EP  - 241
PB  - Cancer Research Campaign
ER  - 

TY  - GEN
TI  - 
JA  - SAS/STAT User's Guide
PY  - 1993///
VL  - 
SP  - 997
EP  - 1025
PB  - Cancer Research Campaign
ER  - 

TY  - JOUR
AU  - Saunders M
AU  - Dische S
AU  - Barrett A
AU  - Harvey A
AU  - Griffiths G
AU  - Parmar M
TI  - Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial
JA  - Radiother Oncol
PY  - 1999///
VL  - 52
SP  - 137
EP  - 148
PB  - Cancer Research Campaign
M3  - 10.1016/S0167-8140(99)00087-0
N1  - 10.1016/S0167-8140(99)00087-0
UR  - http://dx.doi.org/10.1016/S0167-8140(99)00087-0
ER  - 

TY  - JOUR
AU  - Scott C
AU  - Sause WT
AU  - Byhardt R
AU  - Marcial V
AU  - Pajak TF
AU  - Herskovic A
AU  - Cox JD
TI  - Recursive partitioning analysis of 1592 patients on four Radiation Therapy Oncology Group studies in inoperable non-small cell lung cancer
JA  - Lung Cancer
PY  - 1997///
VL  - 17
SP  - 59
EP  - 74
PB  - Cancer Research Campaign
ER  - 

TY  - GEN
TI  - 
JA  - S-Plus 4 Guide to Statistics
PY  - 1991///
VL  - 
SP  - 697
EP  - 710
PB  - Cancer Research Campaign
ER  - 

TY  - GEN
AU  - Sorensen JB
AU  - Osterlind K
TI  - Prognostic factors: from clinical parameters to new biological markers
JA  - Progress and perspective in the treatment of lung cancer
PY  - 1999///
VL  - 
SP  - 1
EP  - 21
PB  - Cancer Research Campaign
ER  - 

TY  - JOUR
AU  - Stevens CW
AU  - Lee JS
AU  - Cox J
AU  - Komaki R
TI  - Novel approaches to locally advanced unresectable non-small cell lung cancer
JA  - Radiother Oncol
PY  - 2000///
VL  - 55
SP  - 11
EP  - 18
PB  - Cancer Research Campaign
M3  - 10.1016/S0167-8140(00)00163-8
N1  - 10.1016/S0167-8140(00)00163-8
UR  - http://dx.doi.org/10.1016/S0167-8140(00)00163-8
ER  - 

TY  - JOUR
AU  - Takigawa N
AU  - Segawa Y
AU  - Okahara M
AU  - Maeda Y
AU  - Takata I
AU  - Kataoka M
AU  - Fujii M
TI  - Prognostic factors for patients with advanced non-small cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation
JA  - Lung Cancer
PY  - 1996///
VL  - 15
SP  - 67
EP  - 77
PB  - Cancer Research Campaign
M3  - 10.1016/0169-5002(96)00571-5
N1  - 10.1016/0169-5002(96)00571-5
UR  - http://dx.doi.org/10.1016/0169-5002(96)00571-5
ER  - 

TY  - JOUR
AU  - Werner-Wasik M
AU  - Scott C
AU  - Cox JD
AU  - Sause WT
AU  - Byhardt RW
AU  - Asbell S
AU  - Russell A
AU  - Komaki R
AU  - Lee JS
TI  - Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally advanced non-small cell lung cancer (LA-NSCLC); identification of five groups with different survival
JA  - Int J Radiat Oncol Biol Phys
PY  - 2000///
VL  - 48
SP  - 1475
EP  - 1482
PB  - Cancer Research Campaign
ER  - 

TY  - JOUR
AU  - Wigren T
TI  - Confirmation of a prognostic index for patients with inoperable non-small cell lung cancer
JA  - Radiother Oncol
PY  - 1997///
VL  - 44
SP  - 9
EP  - 15
PB  - Cancer Research Campaign
ER  - 

